Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: Dengue endangers billions of people in the tropical world, yet no therapeutic is currently available. In part, the severe manifestations of dengue reflect inflammatory processes affecting the vascular endothelium. In addition to lipid lowering, statins have pleiotropic effects that impro...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Journal Article |
| Langue: | anglais |
| Publié: |
2018
|
| Accès en ligne: | https://demo7.dspace.org/handle/123456789/209 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires: Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
- A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
- Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam
- Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial
- Value perception in ultimatum game: a blinded randomized trial